Aktis Oncology, Inc.
AKTS
$20.34
$1.226.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -18.33M | -15.14M | -14.99M | ||
| Total Depreciation and Amortization | 652.00K | 695.00K | 484.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 2.49M | 393.00K | -619.00K | ||
| Change in Net Operating Assets | -9.06M | -1.19M | -2.36M | ||
| Cash from Operations | -24.24M | -15.24M | -17.48M | ||
| Capital Expenditure | -1.85M | -4.15M | -1.89M | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 22.40M | -122.30M | 40.93M | ||
| Cash from Investing | 20.54M | -126.46M | 39.04M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 339.81M | 258.00K | 50.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -2.26M | -1.03M | -518.00K | ||
| Cash from Financing | 337.55M | -772.00K | -468.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 333.85M | -142.47M | 21.09M | ||